Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal IntensiVE Care Patients -3
Not Applicable
- Conditions
- Catheters, IndwellingPreterm BirthCompromised Health
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- Neosense Technologies
- Target Recruit Count
- 50
- Registration Number
- NCT06616012
- Locations
- 🇸🇪
Östra/Sahlgrenska University Hospital, Gothenburg, Halland, Sweden
🇸🇪Skåne University Hospital, Lund/Malmö, Skåne, Sweden
🇸🇪Uppsala University Children's Hospital, Uppsala, Uppland, Sweden
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2
Not Applicable
Terminated
- Conditions
- CatheterLung DiseasesNewborn, Infant, Disease
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Neosense Technologies
- Target Recruit Count
- 8
- Registration Number
- NCT05433779
- Locations
- 🇸🇪
Danderyd Hospital, Danderyd, Sweden
🇸🇪Karolinska University Hospital, Solna, Sweden
🇸🇪Södersjukhuset, Stockholm, Sweden
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients
Not Applicable
Terminated
- Conditions
- Newborn, Infant, DiseaseCathetersOxygen Saturation
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- Neosense Technologies
- Target Recruit Count
- 6
- Registration Number
- NCT03967587
- Locations
- 🇸🇪
Karolinska University Hospital, Huddinge, Sweden
🇸🇪Uppsala University Children's Hospital, Uppsala, Sweden
News
No news found